IPO registrations (S-1, F-1) · Registrants
Biohaven Ltd.
- SEC CIK
- 1935979 · filings on EDGAR ↗
- Former names
- Biohaven Research Ltd. (2022–2022)
- Registration
- Form S-1, first filed 2022-10-18, last 2022-10-20; 1 initial registration, 1 amendment
- Outcome
- Final prospectus filed 2022-10-24; declared effective 2022-10-20
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- D8
- Business address
- 215 CHURCH STREET, New Haven, CT 06510
- Ticker
- BHVN (NYSE)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Biohaven Ltd. on the corporate pages
Offering terms
- Final price
- $10.50 per share (424B4 filed 2022-10-24)
- Shares sold
- 25,000,000
- Gross proceeds
- $262,500,000 before underwriting discounts and any over-allotment option
- Listing
- NYSE under the symbol BHVN
- Lead underwriters
- J.P. Morgan (10,000,000 shares); Cowen (4,437,500 shares); Leerink Partners (4,437,500 shares); Piper Sandler (3,125,000 shares)
- Syndicate
- Cantor Fitzgerald (2,250,000); BTIG (750,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Lobbying client: BIOHAVEN LTD. Fuzzy (name and state)
- SEC filer: Biohaven Ltd. EXACT (CIK (EXACT))
Filings 5
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2022-10-18 | S-1 | S-1 (registration) | Biohaven Ltd. | 0001628280-22-026549 ↗ |
| 2022-10-20 | S-1/A | S-1/A (amendment) | Biohaven Ltd. | 0001628280-22-026728 ↗ |
| 2022-10-20 | S-1MEF | S-1MEF (added securities) | Biohaven Ltd. | 0001628280-22-026778 ↗ |
| 2022-10-20 | EFFECT | EFFECT (declared effective) | Biohaven Ltd. | 9999999995-22-003099 ↗ |
| 2022-10-24 | 424B4 | 424B4 (final prospectus) | Biohaven Ltd. | 0001628280-22-026837 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2022-10-20 | S-1/A | registration statement | $12.40 | 20,000,000 | $248,000,000 | NYSE BHVN | 1 | primary document; price sentence, shares headline, proceeds computed, cover names 1 | document ↗ | |
| 2022-10-24 | 424B4 | final prospectus | $10.50 | 25,000,000 | $262,500,000 | NYSE BHVN | 6 | primary document; price sentence, shares headline, proceeds table, underwriting table 6, cover names 6 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Biohaven Pharmaceutical Holding Co Ltd. | TenPercentOwner | 2 | 2022 | ||
| Buten Matthew | Officer | Chief Financial Officer; Treasurer | 9 | 2022–2026 | |
| Coric Vlad | Director,Officer | Chief Executive Officer | 20 | 2022–2026 | |
| Antonijevic Irina | Director | 7 | 2022–2026 | ||
| Bailey Gregory | Director | 13 | 2022–2026 | ||
| CHILDS JOHN W | Director | 26 | 2022–2026 | ||
| Gentile Kimberly | Officer | SVP, Clinical Operations | 8 | 2022–2026 | |
| GREGORY JULIA P | Director | 7 | 2022–2026 | ||
| Heffernan Michael Thomas | Director | 7 | 2022–2026 | ||
| HUGIN ROBERT J | Director | 7 | 2022–2026 | ||
| Mehta Kishan | Director | 7 | 2022–2026 | ||
| Car Bruce | Officer | Chief Scientific Officer | 8 | 2022–2026 | |
| Clark George C. | Officer | VP, Chief Accounting Officer | 7 | 2022–2026 | |
| Volles Warren Karl | Officer | Chief Legal Officer | 1 | 2026 | |
| Yetimoglu John | Director | 1 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| IPO registrant | Biohaven Pharmaceutical Holding Co Ltd. | CT | IPO registrations (S-1, F-1) | same street address and ZIP code, 215 CHURCH ST 06510 (FUZZY: a shared address, not proof of a shared organization) |
| Lobbying client | BIOHAVEN LTD. | CT | Federal lobbying (LDA) | name and state |
| SEC filer | Biohaven Ltd. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | BIOHAVEN LIMITED | CT | Trademarks (USPTO) | name and state |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, CT first:
- CHIREX INC CT
- ACHILLION PHARMACEUTICALS INC CT
- Rib-X Pharmaceuticals, Inc. CT
- Oracle Healthcare Acquisition Corp. CT
- NANOVIRICIDES, INC. CT
- KOLLTAN PHARMACEUTICALS INC CT
- Trevi Therapeutics, Inc. CT
- Yarrow Bioscience, Inc. CT
- Loxo Oncology, Inc. CT
- ARVINAS, INC. CT
In other datasets, the same topic (Health) in CT:
- Nonprofit: AIDS BUDDY NETWORK (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health